Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies
- 2.6k Downloads
Coffee and caffeine have been linked to type 2 diabetes mellitus (T2DM). A dose–response meta-analysis of prospective studies was conducted to assess the association between coffee and caffeine intake and T2DM incidence.
Pertinent studies were identified by a search of PubMed and EMBASE. The fixed- or random-effect pooled measure was selected based on between-study heterogeneity. Dose–response relationship was assessed by restricted cubic spline.
Compared with the lowest level, the pooled relative risk (95 % CI) of T2DM was 0.71 (0.67–0.76) for the highest level of coffee intake (26 articles involving 50,595 T2DM cases and 1,096,647 participants), 0.79 (0.69–0.91) for the highest level of decaffeinated coffee intake (10 articles involving 29,165 T2DM cases and 491,485 participants) and 0.70 (0.65–0.75) for the highest level of caffeine intake (6 articles involving 9,302 T2DM cases and 321,960 participants). The association of coffee, decaffeinated coffee and caffeine intake with T2DM incidence was stronger for women than that for men. A stronger association of coffee intake with T2DM incidence was found for non-smokers and subjects with body mass index <25 kg/m2. Dose–response analysis suggested that incidence of T2DM decreased by 12 % [0.88 (0.86–0.90)] for every 2 cups/day increment in coffee intake, 11 % [0.89 (0.82–0.98)] for every 2 cups/day increment in decaffeinated coffee intake and 14 % [0.86 (0.82–0.91)] for every 200 mg/day increment in caffeine intake.
Coffee and caffeine intake might significantly reduce the incidence of T2DM.
KeywordsCoffee Caffeine Type 2 diabetes mellitus Dose–response meta-analysis
Conflict of interest
- 1.Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 9785:31–40CrossRefGoogle Scholar
- 3.International Coffee Organization, accessed on 1/6/2013Google Scholar
- 13.Doo T, Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G (2013) Coffee intake and risk of type 2 diabetes: the multiethnic cohort. Public Health Nutr 27:1–9 Google Scholar
- 17.Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stata Journal 6:40–57Google Scholar
- 18.Jackson D, White IR, Thompson SG (2010) Extending DerSimonian and Laird’s methodology to perform multivariate random effects meta-analyses. Stat Med 12:1282–1297Google Scholar
- 25.van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 9344:1477–1478Google Scholar
- 37.van Dam RM, Willett WC, Manson JE, Hu FB (2006) Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged US women. Diabetes Care 2:398–403Google Scholar
- 39.Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 4:979–985Google Scholar
- 42.Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM (2011) Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 10:93Google Scholar
- 50.Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J (1990) Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 5:759–767Google Scholar
- 53.Vazquez G, Duval S, Jacobs DR, Jr., Silventoinen K (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29:115–128Google Scholar
- 55.Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European prospective investigation into cancer and nutrition. Int J Epidemiol 26:S59–70Google Scholar